J&J lines up its Global Head for Actelion
May 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Janssen, Johnson & Johnson
The deal is not yet complete but the last steps are assumed to be a formality – at least Johnson …
Behind the NHS recruitment crisis
May 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS Providers
NHS Providers, the membership organisation and trade association for the NHS, laid a stark warning at the door of the …
Sanofi Zika vaccine deal causes controversy
May 22, 2017Sales and Marketing Sanofi, US army, Zika
In a further twist to Sanofi’s deal with the US Army to develop a vaccine for the Zika virus, the …
Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones
May 22, 2017Manufacturing and Production, Research and Development, Sales and Marketing Novartis
Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …
Amgen hit by major safety blow on osteoporosis drug
May 22, 2017Research and Development, Sales and Marketing Amgen, Romosozumab, UCB SA
Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …
70 patients sue Pfizer over arthritis drug risks
May 22, 2017Sales and Marketing Pfizer, celebrex
Pfizer has been hit with a £3.5 million lawsuit by 70 Scottish patients who claim that the use of its …
AstraZeneca sells off rights to beta-blocker for $300 million
May 22, 2017Sales and Marketing AstraZeneca, Recordati, Seloken
AstraZeneca announced that it had sold the European rights to its drug, Seloken (metoprolol), to Italian pharmaceutical company Recordati. The …
No causal link between Viagra use and melanoma, study finds
May 19, 2017Medical Communications, Research and Development melanoma, viagra
Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …
AbbVie suffers knock to Humira patent
May 19, 2017Medical Communications, Sales and Marketing AbbVie, Humira, patents
Humira is the largest selling pharmaceutical drug in the world. The treatment for rheumatoid arthritis brought in over $16 billion …
Top Ten most popular articles on Pharmafile.com this week
May 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
With every week we draw closer to the event everyone in the UK is talking about – the general election. …
J&J launches lawsuit to block release of Remicade biosimilar
May 19, 2017Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis
Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …
Pharma’s Identity Crisis: Four strategies for creating value in life sciences
May 19, 2017Medical Communications pharmafile
As the demands of healthcare across the world begin to rise, PwC outlines four strategies for creating value in life …
Dr Reddy’s gets greenlight to market Doxil generic
May 18, 2017Sales and Marketing Dr Reddy's, FDA
Dr Reddy’s Laboratories, one of India’s largest pharmaceutical firms, has revealed that the FDA has given the go-ahead to market …
Off-patent cancer drug holds promise for severe asthma treatment
May 18, 2017Research and Development asthma, imatinib
Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …
FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years
May 18, 2017Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als
The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …
Research suggests opioid crisis stems from prescription approach
May 18, 2017Medical Communications, Research and Development opioid crisis, opioids
The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …
500 staff face the axe as Teva cans Hungary plant
May 18, 2017Manufacturing and Production Teva
Israeli pharmaceutical firm Teva has announced that it plans to cease operations at a manufacturing plant in Gödöllő in Budapest, …
AZ launches lawsuit against former executive for defecting to GSK
May 17, 2017Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline
AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …
Bayer celebrates FDA priority review for investigational blood cancer drug
May 17, 2017Research and Development, Sales and Marketing Bayer, FDA, blood cancer
Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …
T cells found to ‘acquire knowledge’ to take fight to metastatic cancer
May 17, 2017Research and Development Cancer, T cell, immunotherapy
T cells are widely known as being crucial in the fight against cancer within the body but little was known, …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
